The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 398,927 | 82,423 | SH | SOLE | 82,423 | 0 | 0 | |||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 793,901 | 115,898 | SH | SOLE | 115,898 | 0 | 0 | |||
ALPHABET INC | CAP STK CL C | 02079K107 | 13,185 | 100 | SH | SOLE | 100 | 0 | 0 | |||
ARDELYX INC | COM | 039697107 | 4,800,801 | 1,176,667 | SH | SOLE | 1,176,667 | 0 | 0 | |||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 824,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
BATTALION OIL CORPORATION | COM | 07134L107 | 2,353,906 | 380,891 | SH | SOLE | 380,891 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 1,615,018 | 531,256 | SH | SOLE | 531,256 | 0 | 0 | |||
BURGERFI INTERNATIONAL INC | COM | 12122L101 | 3,185,288 | 2,745,938 | SH | SOLE | 2,745,938 | 0 | 0 | |||
BURGERFI INTERNATIONAL INC | *W EXP 12/16/202 | 12122L119 | 235,428 | 2,083,438 | SH | Call | SOLE | 2,083,438 | 0 | 0 | ||
CHEVRON CORP NEW | COM | 166764100 | 7,757 | 46 | SH | SOLE | 46 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,228,957 | 82,425 | SH | SOLE | 82,425 | 0 | 0 | |||
DURECT CORP | COM NEW | 266605500 | 1,064,363 | 427,455 | SH | SOLE | 427,455 | 0 | 0 | |||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 826,100 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
HARPOON THERAPEUTICS INC | COM NEW | 41358P205 | 332,306 | 82,458 | SH | SOLE | 82,458 | 0 | 0 | |||
HUMACYTE INC | COM | 44486Q103 | 688,550 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 1,775,959 | 70,335 | SH | SOLE | 70,335 | 0 | 0 | |||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 29,162,100 | 165,000 | SH | Put | SOLE | 165,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 2,270,103 | 130,691 | SH | SOLE | 130,691 | 0 | 0 | |||
LUMOS PHARMA INC | COM | 55028X109 | 299,620 | 90,794 | SH | SOLE | 90,794 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 17,269,963 | 2,145,337 | SH | SOLE | 2,145,337 | 0 | 0 | |||
MICROSOFT CORP | COM | 594918104 | 31,575 | 100 | SH | SOLE | 100 | 0 | 0 | |||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,395,642 | 450,207 | SH | SOLE | 450,207 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 853,200 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 598,850 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
SEMTECH CORP | COM | 816850101 | 63,161,016 | 2,452,855 | SH | SOLE | 2,452,855 | 0 | 0 | |||
SEMTECH CORP | COM | 816850101 | 64,375,000 | 2,500,000 | SH | Call | SOLE | 2,500,000 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 1,646,491 | 691,803 | SH | SOLE | 691,803 | 0 | 0 | |||
SPDR S&P 500 ETF TRUST | TR UNIT | 78462F103 | 21,374,000 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 500,940 | 34,500 | SH | SOLE | 34,500 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 697,320 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 647,930 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 |